Evidence map›Paper›PMID 41112868›Full record

ArticleACS nanoscience Au2025

On The Retrograde Transport of RNA-Loaded Lipid Nanoparticles Designed for Brain Delivery.

Stefania Mamberti, Cristiano Pesce, Greta Avancini, Gonna Somu Naidu, Govinda Reddy Kundoor, Corinne Portioli, Dan Peer, Paolo Decuzzi, Roberto Palomba

Abstract read
In one paragraph

Article in ACS nanoscience Au, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Stefania MambertiLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.ORCID https://orcid.org/0000-0001-9099-953X
Cristiano PesceLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.
Greta AvanciniLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.ORCID https://orcid.org/0000-0001-8792-342X
Gonna Somu NaiduLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv-Yafo 69978, Israel.ORCID https://orcid.org/0000-0003-4822-0259
Govinda Reddy KundoorLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv-Yafo 69978, Israel.
Corinne PortioliLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.
Dan PeerLaboratory of Precision Nanomedicine, Shmunis School of Biomedicine and Cancer Research, Tel Aviv University, Tel Aviv-Yafo 69978, Israel.ORCID https://orcid.org/0000-0001-8238-0673
Paolo DecuzziLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.ORCID https://orcid.org/0000-0001-6050-4188
Roberto PalombaLaboratory of Nanotechnology for Precision Medicine, Italian Institute of Technology, Genoa 16163, Italy.ORCID https://orcid.org/0000-0002-9715-3876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipid nanoparticles (LNP) have been extensively studied for their ability to encapsulate and protect RNA molecules from degradation. More recently, a few studies have begun to explore their applications as carriers for brain drug delivery via various administration routes. Nose-to-brain delivery represents a promising alternative to both invasive local injections and systemic administration, offering the possibility to bypass the blood-brain barrier and directly access the brain, achieve rapid absorption, reduce systemic exposure, and allow for ease of administration. In order to evaluate the viability of this alternative route, it is essential to acquire a better understanding of the intraneuronal mass transport of LNP, particularly in terms of how effectively and efficiently they deliver their payloads from the periphery to neuronal cell bodies. However, most previous studies have focused primarily on the delivery vector itself rather than on the fate of the transported cargo. In this study, we investigate the retrograde trafficking of nucleic acid-loaded LNP in primary cortical neurons, focusing on the transport of both the particle and the payload. Three distinct LNP were formulated to characterize different aspects of their interaction with the cells, with the major LNP player of this study containing a red-fluorescent Rhodamine B-tagged lipid and a green fluorescently FAM-tagged RNA. Flow cytometry was used to document LNP uptake by primary cortical neurons over time. Additionally, confocal microscopy was then used to investigate the colocalization of LNP and RNA after a conventional 2D culture treatment. As a final step, a compartmentalized chip that separates the somal and the axonal regions of cortical neurons was used to study the intraneuronal dynamics of LNP and their cargo. In this second setup, LNP were selectively administered at the axonal compartment, and the fluorescent signals from the vector (red) and the payload (green) were imaged through time-lapse microscopy. The progressive accumulation of RNA found at cellular bodies also in the absence of the red signal suggested an efficient retrograde transport of the LNP payload toward the soma. Comprehensively, this work demonstrates that primary cortical neurons are capable of efficiently uptaking LNP and of intracellularly transporting both LNP and their RNA cargo. Interestingly, a different colocalization trend (LNP-RNA) emerged depending on the followed setup. Localized axonal transfection appeared to favor dissociation of RNA from the LNP and subsequent accumulation at the soma. Overall, our work provides a fundamental in vitro proof of concept of the RNA delivery to the cellular bodies of primary cortical neurons via the retrograde transport of LNP vectors administered at the axonal termini. This finding, together with the image-analysis-based quantification of the RNA accumulation described in our work, paves the way for future studies aimed at designing lipid-based nanoparticles for RNA therapeutic delivery to the brain via peripheral administration.

Indexed as

axonal retrograde transportionizable lipidsLNPlocal transfectionmicrofluidic chipprimary cortical neuronsRNA

Identifiers

PMID41112868
PMCPMC12531864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.